Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: Comparison between humans and rats

Journal of Cellular Biochemistry

Volumn 96, Issue 2, 2005, Pages 404-411

  Trudel, K ^a   Sinnett, D ^a   James, R W ^b   Delvin, E ^a   Amre, D ^a   Seidman, E ^a   Levy, E ^a,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

HDL3; Liver microsomes; Oxidative stress; PON1

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; ASCORBIC ACID; CARBOXYLESTERASE; HIGH DENSITY LIPOPROTEIN; IRON; MALONALDEHYDE; THIOBARBITURIC ACID;

ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; LIVER MICROSOME; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

ANIMALS; ARYLDIALKYLPHOSPHATASE; ASCORBIC ACID; HUMANS; IRON; LIPOPROTEINS, HDL; LIVER; MICROSOMES; OXIDANTS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 26444492713     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20542     Document Type: Article

References (31)

1. Ashby DT, Rye KA, Clay MA, Vadas MA, Gamble JR, Barter PJ. 1998. Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells. Arterioscler Thromb Vasc Biol 18:1450-1455.
2. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. 1998. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101:1581-1590.
3. Bachowski GJ, Thomas JP, Girotti AW. 1988. Ascorbate-enhanced lipid peroxidation in photooxidized cell membranes: Cholesterol product analysis as a probe of reaction mechanism. Lipids 23:580-586.
4. Barter P, Kastelein J, Nunn A, Hobbs R. 2003. High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions. Atherosclerosis 168:195-211.
5. Bernotti S, Seidman E, Sinnett D, Brunet S, Dionne S, Delvin E, Levy E. 2003. Inflammatory reaction without endogenous antioxidant response in Caco-2 cells exposed to iron/ascorbate-mediated lipid peroxidation. Am J Physiol Gastrointest Liver Physiol 285:G898-G906.
6. Blatter MC, James RW, Messmer S, Barja F, Pometta D. 1993. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem 211:871-879.
7. Blomhoff R. 2005. Dietary antioxidants and cardiovascular disease. Curr Opin Lipidol 16:47-54.
8. Brasitus TA, Davidson NO, Schachter D. 1985. Variations in dietary triacylglycerol saturation alter the lipid composition and fluidity of rat intestinal plasma membranes. Biochim Biophys Acta 812:460-472.
9. Brunet S, Thibault L, Delvin E, Yolov W, Bendayan M, Levy E. 1999. Dietary iron overload and induced lipid peroxidation are associated with impaired plasma lipid transport and hepatic sterol metabolism in rats. Hepatology 29:1809-1817.
10. Brunet S, Thibault L, Lepage G, Seidman EG, Dube N, Levy E. 2000. Modulation of endoplasmic reticulum-bound cholesterol regulatory enzymes by iron/ascorbate-medialed lipid peroxidation. Free Radic Biol Med 28:46-54.
11. Chemnitius JM, Losch H, Losch K, Zech R. 1983. Organophosphate detoxicating hydrolases in different vertebrate species. Comp Biochem Physiol C 76:85-93.
12. Djordjevic VB. 2004. Free radicals in cell biology. Int Rev Cytol 237:57-89.
13. Gunawan B, Kaplowitz N. 2004. Clinical perspectives on xenobiotic-induced hepatotoxicity. Drug Metab Rev 36:301-312.
14. Hovingh GK, de Groot E, van der SW, Boekholdt SM, Hutten BA, Kuivenhoven JA, Kastelein JJ. 2005. Inherited disorders of HDL metabolism and atherosclerosis. Curr Opin Lipidol 16:139-145.
15. Jourd'Heuil D, Vaananen P, Meddings JB. 1993. Lipid peroxidation of the brush-border membrane: Membrane physical properties and glucose transport. Am J Physiol 264:G1009-G1015.
16. Kehrer JP, Lund LG. 1994. Cellular reducing equivalents and oxidative stress. Free Radic Biol Med 17:65-75.
17. Kelso GJ, Stuart WD, Richter RJ, Furlong CE, Jordan-Starck TC, Harmony JA. 1994. Apolipoprotein J is associated with paraoxonase in human plasma. Biochemistry 33:832-839.
18. Kontush A, Chantepie S, Chapman MJ. 2003. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol 23:1881-1888.
19. La Du BN. 1992. Human serum paraoxonase/arylesterase. In: Kalow W, editor. Pharmacogenetics of drug metabolism. New-york: pp 51-91.
20. Levy E, Thibault LA, Roy CC, Bendayan M, Lepage G, Letarte J. 1988. Circulating lipids and lipoproteins in glycogen storage disease type I with nocturnal intragastric feeding. J Lipid Res 29:215-226.
21. Levy E, Thibault L, Garofalo C, Messier M, Lepage G, Ronco N, Roy CC. 1990. Combined (n-3 and n-6) essential fatty deficiency is a potent modulator of plasma lipids, lipoprotein composition, and lipolytic enzymes. J Lipid Res 31:2009-2017.
22. Mackness MI, Arrol S, Durrington PN. 1991. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 286:152-154.
23. Navab M, Berliner JA, Subbanagounder G, Hama S, Lusis AJ, Castellani LW, Reddy S, Shih D, Shi W, Watson AD, Van Lenten BJ, Vora D, Fogelman AM. 2001. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol 21:481-488.
24. Poet TS, Wu H, Kousba AA, Timchalk C. 2003. In vitro rat hepatic and intestinal metabolism of the organophosphate pesticides chlorpyrifos and diazinon. Toxicol Sci 72:193-200.
25. Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, Gangopadhyay A, Shih DM, Lusis AJ, Navab M, Fogelman AM. 2001. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 21:542-547.
26. Rohrer L, Hersberger M, von Eckardstein A. 2004. High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr Opin Lipidol 15:269-278.
27. Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ. 1998. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394:284-287.
28. Stocker R, Keaney JF, Jr. 2004. Role of oxidative modifications in atherosclerosis. Physiol Rev 84:1381-1478.
29. Tward A, Xia YR, Wang XP, Shi YS, Park C, Castellani LW, Lusis AJ, Shih DM. 2002. Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation 106:484-490.
30. Varga M. 1992. Understanding the role of oxyradicals in general and in toxic hepatic damage can help safer drug design. Med Hypotheses 39:133-136.
31. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M. 1995. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 96:2882-2891.